You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Prometh Hydrochloride,phenylephrine Hydrochloride W patents expire, and when can generic versions of Prometh Hydrochloride,phenylephrine Hydrochloride W launch?

Prometh Hydrochloride,phenylephrine Hydrochloride W is a drug marketed by Genus Lifesciences and is included in one NDA.

The generic ingredient in PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W?
  • What are the global sales for PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W?
  • What is Average Wholesale Price for PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W?
Summary for PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W
US Patents:0
Applicants:1
NDAs:1
DailyMed Link:PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W at DailyMed
Drug patent expirations by year for PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W

US Patents and Regulatory Information for PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Genus Lifesciences PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride SYRUP;ORAL 040660-001 Dec 7, 2006 AA RX No Yes ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.